In parallel with clinical trial support IHMA fully supports other laboratory studies that are an important part of a regulatory filing. These studies carefully investigate various aspects of drug-organism interactions and may be undertaken before or during the clinical development phase. Such studies include, but may not be limited to, bacterial killing, resistance development, drug interactions, and quality control guidelines.